Real-world practice patterns of eplerenone use for central serous chorioretinopathy.

ABSTRACT:

Purpose

To report eplerenone use by retina specialists worldwide for central serous chorioretinopathy (CSCR).

Methods

A self-reporting questionnaire was distributed to retina specialists worldwide to gather clinicians' perspectives on CSCR cases treated, eplerenone dosage and duration, reasons to use it, and side effects.

Results

The survey included 241 retina specialists (122 Indian and 119 international) with an average experience of 15.69 ± 9.59 years. Oral eplerenone was used to treat CSCR by 149 (62%) participants. Only 6% (n = 9) had easy access to verteporfin dye and photodynamic therapy. 30 (20%) of the 149 respondents changed their treatment with eplerenone after VICI trial results. Eplerenone was prescribed mostly for chronic CSCR (n = 86, 58%), regardless o

SUBMITTER: Venkatesh R 

PROVIDER: S-EPMC10544617 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature